Purpose of the Study: This study was conducted to detect and characterize the genes encoding extended spectrum β-lactamases and associated β-lactamases (carbapenemases and Ambler Class C β-lactamases).
INTRODUCTION
Since their description in the mid-1980s, extended spectrum β-lactamase (ESBL)-producing organisms have become recognized as a worldwide problem. 1 Although ESBLs have been detected in a wide variety of Gram-negative bacteria, Klebsiellapneumoniae has been found to be the This study was conducted to detect and characterize ESBLs and associated β-lactamases (carbapenemases and Ambler Class C β-lactamases (AmpC)) produced by K. pneumoniae resistant to 3 rd generation cephalosporin (3 rd GC) causing bacteremia at Charles Nicolle Hospital, during 2011.
MATERIALS AND METHODS

Bacterial Isolates
Among the 65 non-duplicate K. pneumoniae isolated from blood cultures of 65 patients hospitalized at Charles Nicolle Hospital of Tunis from January to December 2011, 36 (55.3%) were resistant to 3 rd GC. They were collected mainly from intensive care unit (31%), neonatology (26%) and surgery (23%) ( Table 1) .
Antibiotic Susceptibility Testing
Antimicrobial susceptibility testing was determined by the disk-diffusion method on Mueller-Hinton (MH) agar plates (Bio-Rad, Marnes-la-Coquette, France) according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.
9 ESBL production was detected by the double disk synergy test (DDST) with or without cloxacillin as described previously. 10 Isolates with reduced susceptibility to carbapenems: imipenem (diameter zone ≤ 22 mm) and/or ertapenem (diameter zone ≤ 18 mm) were subjected to the modified Hodge screening test (MHT) for diffusible carbapenemase detection as previously described. 11 The minimal inhibition concentrations (MICs) of ceftazidime, ceftazidime-clavulanic acid, cefotaxime, cefoxitine and cefepime were determined by agar dilution technique. For imipenem, ertapenem and meropenem, MICs were determined by E-test (Bio-Mérieux SA, Marcy l'étoile, France). Results were interpreted according to the CLSI guidelines.
9
Detection of β-lactamase-encoding Genes K. pneumoniae isolates were screened by PCR for the following β-lactamases encoding genes: bla CTX-M phylogenetic lineage groups 1, 2 and 9, 12-14 bla TEM , bla SHV , bla CIT , bla ACC, bla EBC, bla MOX, bla FOX , bla DHA , bla LAT , bla ACT, bla MIR ,
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bla OXA-48 and bla KPC 16 as described previously.The PCR products were purified with a Purification Kit (BioMatik) and sequenced on an ABI PRISM 310 DNA Sequencer (Applied Biosystems). The nucleotide sequences were analyzed with the BLAST program (http://www.ncbi.nlm. nih.gov/BLAST/).
β-Lactam Resistance Transfer Assays
Conjugation assays were performed on 5 isolates selected on the basis of their susceptibility to rifampin. It was carried out in brain heart broth (Bio-Rad), with E. coli J53-2 as the recipient. Transconjugants were selected on Mueller Hinton agar plates containing rifampicin (500 mg/L) and ticarcillin (125 mg/L). If not successful at the first attempt, mating experiments were repeated up to 3 times. Transconjugant's were submitted to bacterial identification with the API-20E system (Bio-Mérieux SA, Marcy l'étoile, France), antibiotic susceptibility testing and PCR amplification of the bla genes mentioned above.
Incompatibility Groups
Incompatibility groups (Inc) were determined by PCRbased replicon typing method as previously described.
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RESULTS
Antibiotic Susceptibility Tests
All isolates showed a positive DDST. They showed high level of resistance to cefotaxime (MIC 50 = 512 µg/mL), ceftazidime (MIC 50 =128 µg/mL) and cefepime (MIC 50 =128 µg/mL). MICs of ceftazidime decreased when clavulanic acid is added. However, 1 strain showed high level of resistance to cefoxitin (MIC=>512 µg/mL) ( Table 1 ). Five strains were resistant to ertapenem and showed a positive MHT. Three of them were resistant to imipinem and/or meropenem ( Table 1 ).
All isolates were resistant to most antibiotics tested except colistin and tigecylin.They were frequently resistant to tobramycin (n=35), gentamicin (n=28), tetracycline (n=19), trimethoprim-sulfamethoxazole (n=30) and fluoroquinolones (n=26).
β-Lactamases Gene Characterization
The results of PCR and sequence analysis are summarized in Table 1 . The bla SHV-1 gene was detected in all K. pneumoniae strains. ESBL genes were detected in all strains, bla CTX-M-15 in 35 strains and bla SHV-12 in one. Moreover, 28 isolates harbored bla TEM-1 . Ertapenem resistant strains carried bla OXA-48 . The bla CMY-2 genewas detected in one strain that also coproduce 3 β-lactamases genes (bla CTX-M-15 , bla OXA-48 and bla TEM-1 ).
Plasmid Replicon Type Determination
For 2 strains, the plasmids carrying bla CTX-M-15 were assigned to the IncN and IncL/M replicon type. However, the remaining bla CTX-M-15 -carrying plasmid was negative for all of the replicons tested, as well as the bla SHV-12 -carrying plasmid (Table 1) .
ESBL Transfer
Theconjugationwassuccessfulfor4/5 strains (3 harboring bla CTX-M-15 and one bla ). We also observed co-transfer, following conjugation, of resistance to other antibiotics, such as i.e. gentamicin (n=1), tobramycin (n=2), netilmicin (n=1), minocycline (n=4) and chloramphenicol (n=2). 
Production of ESBLs was detected in all transconjugants
DISCUSSION
ESBL producing K. pneumoniae is one of the most important pathogens responsible for life threatening infections.
4,18,19
In the present study, frequency of ESBL producing K. pneumoniae causing bacteremia is 47% which is lower than 87.5% reported in a Tunisian pediatric intensive care unit. 4 A study conducted in India reported 56% ESBL K. pneumoniae causing septicemiaamongneonates.
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In most European countries, Latin America, and East Asia, CTX-M variants have displaced TEM and SHV enzymesas the predominant β-lactamases produced by Gram-negative bacteria such as K. pneumoniae. 20 Our work shows that CTX-M-15 is the most common ESBL. CTX-M-15, first described in India in 1999, 21 has spread over the world, and seems to be the most common ESBL type. 22, 23 In Tunisia, dissemination of CTX-M-15 has been reported in K. pneumoniae, E. coli and Enterobacter cloacae strains.
2,5,24,25
bla CTX-M-15 gene is generally found on large conjugative plasmids and is located downstream of an ISEcp1 insertion sequence which explains its remarkable transmission success. 26 The large use of 3 rd GC in clinical practice has significantly contributed to their selection.
27
Although SHV-12 was found in one isolate of our collection, previous Tunisian studies showed that this enzyme was associated with K. pneumoniaeinvolved in nosocomial outbreaks. 2, 3, 20, 28, 29 Worldwide, the distribution of SHVESBLs showed that SHV-2, SHV-4 and SHV-5 enzymes are the most prevalent in the United States and Europe. 30 The ESBL-producing organisms additionally exhibited co-resistance against multiple antimicrobials from other classes, such as tetracycline, aminoglycosides and fluoroquinolones. This complexity in antimicrobials resistance combinations limits suitable drug of choice for antimicrobial therapy, leaving carbapenems the last options for treatment in some cases. However, the emergence of plasmidiccarbapenemases producers clearly compounds potential treatment options.
14 Carbapenem resistance was found in 5 of our strains. All harbored OXA-48. This class D carbapenemasewas first identified in K. pneumoniae from Turkey in 2003 16 and then extensively spread in other countries 31 and species. In Tunisia, recent studies reported the spread of OXA-48 producing Enterobacteriaceae. 32, 33 bla CMY-2 is the most frequently encountered plasmid encoded AmpC-type β-lactamase gene found in E. coli worldwide. [34] [35] [36] the first AmpC type β-lactamase to be identified in Tunisia was in 1996 in a P. mirabilis isolate, and was characterized as a CMY-4 enzyme. 37 In Tunisia, CMY-2 has already been detected in food samples 34 and fecal flora of healthy chickens and pets 38 but never in clinical isolates. In our study, bla CMY-2 was detected in one strain, which co-produced 3 plasmidicβ-lactamases (CTX-M-15, OXA-48 and TEM-1). The coexistence of several enzymes in the same strain is noteworthy and has been previously described in K. pneumoniae in Tunisia (VIM-4, CTX-M-15 and CMY-4). 39 Identification and classification of plasmids harbouring β-lactamases is helpful to analyze their distribution in nature and their relationship to host cells and to discover their evolutionry origins. 40 In our study, incompatibility groups of bla CTX-M-15 carrying plasmids were determined only in 2 strains (IncN and IncL/M). However, other studies reported that some bla CTX-M-15 and bla SHV-12 -carrying plasmids were negative for all of the replicons tested, 2, 28 as well as described in our study. Further research is necessary to provide more information about our plasmids.
In conclusion, our study reports a widespread diffusion of CTX-M-15 with the emergence of OXA-48 in K. pneumoniae in Tunisia which seriously limits therapeutic options in cases of clinical infections with these bacteria. In addition, coexistence of ESBLs production with cephalosporinase or carbapenemase is a serious public health problem and requires continuous surveillance, monitoring and revision of the antibiotic use policies. 
